NTSAD officially has launched a webinar series to bring the experts to the community to discuss topics ranging from research advances to issues that impact the family. As is custom, NTSAD will post the recording of each webinar without the Q&A that follows each presentation.
Wednesday, August 7, 2019
IntraBio and IB1001 Clinical Trials
Taylor Fields, Senior VP, IntraBio
A presentation about IntraBio's compound, IB1001, the clinical trials in the US and Europe, and the hope that it has a positive impact on the GM2 Gangliosidoses (Tay-Sachs and Sandhoff). Facilitated by Staci Kallish, DO, NTSAD Board president.